The American Herbal Products Association is presenting in August a two-day Hemp-CBD Supplement Congress in Denver, Colorado, for companies looking to manufacture and market dietary supplement products with hemp or hemp-derived ingredients.
The workshops and presentations will address the rapidly evolving legal, regulatory and financial landscapes surrounding hemp products, including cannabidiol (CBD). Speakers from the Food and Drug Administration and the U.S. Department of Agriculture will discuss their agencies’ approach to regulating hemp-CBD and supplements made with these ingredients.
Scheduled for Aug. 15 and 16, the event will be at the Crowne Plaza Denver, 1450 Glenarm Place, Denver. Registration is available on the AHPA website. The costs for AHPA members are $275 for Thursday’s workshops and $449 for Friday’s Congress; non-members’ costs are $325 and $575, respectively. Those who register by July 1 will save $50.
Thursday’s half-day workshops will cover two regulatory issues: compliance with the FDA’s current good manufacturing practice (cGMP) requirements for dietary supplements; and new dietary ingredient and generally recognized as safe for hemp as a food additive or dietary ingredient. EAS Consulting Group will provide cGMP training, while AIBMR Life Sciences will present NDI and GRAS requirements.
Friday, industry experts and government officials will present on a host of issues facing hemp-CBD companies:
- Getting to Market: Hemp Supply Chain Management
- Overcoming Regulatory Obstacles: Updates from the FDA, USDA and Individual States
- Primer on FDA Regulation of Hemp-CBD Supplements
- The Hemp-CBD Supplement Market: A Financial Snapshot
- Hemp-CBD Supplements from the Retailers' Perspective
Notable sessions include a presentation from USDA Agricultural Marketing Service senior marketing specialist William Richmond, who will provide an update on USDA efforts related to the recent decriminalization of hemp. In addition, the FDA will provide an update on the agency's ongoing efforts to design and implement a regulatory framework to ensure informed access to safe, legal products. Richmond leads the USDA, Agricultural Marketing Service, Specialty Crops Program in Washington, D.C., and is responsible for establishment and implementation of the U.S. Domestic Hemp Production Program.
According to the latest research, hemp-CBD sales are projected to surpass $15 billion - $20 billion in the U.S. by 2024, indicating an immediate need for manufacturers and retailers to understand the role of hemp in the dietary supplement category.
“The U.S. market for hemp-derived CBD in dietary supplements is growing and evolving rapidly and companies that manufacture and sell CBD supplements face a host of challenges and opportunities. AHPA’s Congress will provide companies with the information needed to successfully navigate challenges and take advantage of opportunities,” AHPA President Michael McGuffin said in a released statement. “FDA and USDA officials will join legal and industry experts to provide compliance strategies for dietary supplement regulatory requirements to help companies meet the growing consumer demand for high-quality, safe products.”
Source: American Herbal Products Association